Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

por Kim, George P, Grothey, Axel
Publicado 2008

N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma

por Halfdanarson, Thorvardur R, Foster, Nathan R, Kim, George P, Haddock, Michael G, Dakhil, Shaker R, Behrens, Robert J, Alberts, Steven R
Publicado 2022

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Cent...

por Halfdanarson, Thorvardur R., Foster, Nathan R., Kim, George P., Meyers, Jeffrey P., Smyrk, Thomas C., McCullough, Ann E., Ames, Matthew M., Jaffe, Jeffrry P., Alberts, Steven R.
Publicado 2019

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

por Alberts, Steven R., Yu, Tiffany M., Behrens, Robert J., Renfro, Lindsay A., Srivastava, Geetika, Soori, Gamini S., Dakhil, Shaker R., Mowat, Rex B., Kuebler, John P., Kim, George P., Mazurczak, Miroslaw A., Hornberger, John
Publicado 2014